Dipeptidyl peptidase IV: An attractive target for the development of effective diagnostic and therapeutic strategies
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2018, Vol 72, Issue
Abstract
DPP IV is a peptidase with a catalytic activity and the ability to bind extracellular matrix proteins. It participates in the metabolism of glucose, gastrointestinal motility, the regulation of appetite and affects the function of the immune system. It is also involved in the formation of pain and inflammation. The variety of activities due to extensive expression in endothelial and epithelial cells makes the enzyme a promising tool for diagnostic and prognostic applications. The natural DPP IV peptide inhibitors and substrates have inspired the search for new, therapeutically important compounds that selectively inhibit the enzyme activity. A number of changes to the structure of the parent molecules have been required to improve their pharmacokinetic and pharmacodynamic profile to achieve therapeutic efficacy. The several synthetic scaffold mimetics, known as gliptins, are now in clinical use in the treatment of diabetes mellitus type 2. Recent studies indicate that gliptin inhibitors may be of therapeutic interest or inspiration for the development of new drugs for other diseases such as cancer, inflammatory, degenerative diseases, metabolic and neurological disorders or dysfunctions of the immune system.<br/><br/>
Authors and Affiliations
Agata Jackiewicz, Joanna Katarzyńska
Amylina w badaniach eksperymentalnych. Fibrylotwórczy polipeptydowy hormon trzustki
W przebiegu cukrzycy typu 2 (diabetes mellitus type 2 DM2, non-insulin dependent diabetes mellitus, NIDDM) oraz w rozwoju guza insulinowego trzustki, obserwuje się w obrębie wysp Langerhansa, patologiczne depozyty zwane...
Wpływ insulinopodobnego czynnika wzrostu IGF-1 na wewnątrzmaciczny proces wzrastania płodu w ciąży powikłanej cukrzycą ciążową
Insulinopodobny czynnik wzrostu (IGF-1, insulin-like growth factor 1) jest jednym z elementów składowych układu insulinopodobnych czynników wzrostu charakteryzujący się strukturalnym, a także czynnościowym podobieństwem...
Regulatory lymphocytes in thyroid orbitopathy and autoimmune thyroid diseases
Thyroid orbitopathy (OT), as an organ‑specific autoimmune disease, is a result of immune dysregulation leading to loss of control over inflammation directed against self‑antigens. The source of the autoreactive lymphocyt...
Metabolic disorders and nutritional status in autoimmune thyroid diseases
In recent years, the authors of epidemiological studies have documented that autoimmune diseases are a major problem of modern society and are classified as diseases of civilization. Autoimmune thyroid diseases (ATDs) ar...
Ubiquitination, quality control and degradation of membrane proteins – chance for therapies?
Plasma membrane integrity maintenance is crucial for cell survival. Plasma membrane proteins are under tight regulation and under certain conditions are actively removed from the membrane allowing cells to adapt to chang...